InMed Pharmaceuticals Statistics

Total Valuation

FRA:MWG has a market cap or net worth of EUR 2.97 million. The enterprise value is -2.52 million.

Market Cap	2.97M
Enterprise Value	-2.52M

Important Dates

The last earnings date was Thursday, February 5, 2026.

Earnings Date	Feb 5, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	2.92M
Shares Outstanding	n/a
Shares Change (YoY)	+359.88%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.77
PB Ratio	0.36
P/TBV Ratio	0.43
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.39
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.94, with a Debt / Equity ratio of 0.06.

Current Ratio	5.94
Quick Ratio	4.85
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-392.09

Financial Efficiency

Return on equity (ROE) is -97.20% and return on invested capital (ROIC) is -56.82%.

Return on Equity (ROE)	-97.20%
Return on Assets (ROA)	-49.77%
Return on Invested Capital (ROIC)	-56.82%
Return on Capital Employed (ROCE)	-80.75%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	295,251
Profits Per Employee	-502,134
Employee Count	13
Asset Turnover	0.46
Inventory Turnover	3.09

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -77.18% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-77.18%
50-Day Moving Average	0.90
200-Day Moving Average	1.72
Relative Strength Index (RSI)	35.95
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.48

Income Statement

In the last 12 months, FRA:MWG had revenue of EUR 3.84 million and -6.53 million in losses. Loss per share was -2.49.

Revenue	3.84M
Gross Profit	1.14M
Operating Income	-6.68M
Pretax Income	-6.53M
Net Income	-6.53M
EBITDA	-6.50M
EBIT	-6.68M
Loss Per Share	-2.49

Full Income Statement

Balance Sheet

The company has 5.96 million in cash and 453,061 in debt, with a net cash position of 5.51 million.

Cash & Cash Equivalents	5.96M
Total Debt	453,061
Net Cash	5.51M
Net Cash Per Share	n/a
Equity (Book Value)	8.17M
Book Value Per Share	2.91
Working Capital	6.22M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-6.32M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 29.73%, with operating and profit margins of -174.01% and -170.07%.

Gross Margin	29.73%
Operating Margin	-174.01%
Pretax Margin	-170.07%
Profit Margin	-170.07%
EBITDA Margin	-169.32%
EBIT Margin	-174.01%
FCF Margin	n/a

Dividends & Yields

FRA:MWG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-359.88%
Shareholder Yield	-359.88%
Earnings Yield	-219.74%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 14, 2024. It was a reverse split with a ratio of 0.05.

Last Split Date	Nov 14, 2024
Split Type	Reverse
Split Ratio	0.05

Scores

FRA:MWG has an Altman Z-Score of -14.76 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-14.76
Piotroski F-Score	3